Theseus Pharmaceuticals Inc. (THRX) NASDAQ
$4.06 - (-)
Market Cap: -
As of 02/13/24 12:00 AM EST. Market closed.
Theseus Pharmaceuticals Inc. (THRX)
NASDAQ
$4.06
- (-)
Market Cap: -
As of 02/13/24 12:00 AM EST. Market closed.
Add to Portfolio
theseus pharmaceuticals is passionately committed to outsmarting cancer resistance. cancer is constantly mutating, allowing it to evade initially effective oncology treatments. theseus believes we can predict how cancer will change, enabling new therapies to stay ahead of future mutations and overcome the demonstrated burden of treatment resistance. led by a team of pioneers in the discovery and ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
PRICE CHART FOR THESEUS PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$4.06
Days Range
- - -
52 week range
- - -
Volume
1,983,441
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
44,230,135
Open
-
Previous Close
$4.06
Days Range
- - -
52 week range
- - -
Volume
1,983,441
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
44,230,135
FINANCIAL STATEMENTS FOR THESEUS PHARMACEUTICALS INC
LOADING...
INSIDER TRANSACTIONS FOR THESEUS PHARMACEUTICALS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Shakespeare William | See Remarks | Nov 06, 2023 | Option Exercise | $0.32 | 251,084 | 80,347 | 639,408 | Nov 07, 2023, 04:03 PM |
GORDON CARL L | Director | Jul 17, 2023 | Buy | $3.05 | 479,932 | 1,463,793 | 17,063,000 | Jul 19, 2023, 04:17 PM |
ORBIMED ADVISORS LLC | Director | Jul 17, 2023 | Buy | $3.05 | 479,932 | 1,463,793 | 17,063,000 | Jul 19, 2023, 04:15 PM |
Foresite Capital Management V, LLC | 10% Owner | Jul 17, 2023 | Buy | $2.97 | 700,000 | 2,079,000 | 4,108,796 | Jul 19, 2023, 02:54 PM |
Foresite Capital Management V, LLC | 10% Owner | Dec 29, 2022 | Buy | $5.00 | 500,000 | 2,500,000 | 3,585,346 | Jan 03, 2023, 04:24 PM |
HAYDEN DONALD J JR | Director | Dec 30, 2022 | Buy | $5.00 | 9,900 | 49,489 | 10,000 | Jan 03, 2023, 07:05 AM |
HAYDEN DONALD J JR | Director | Dec 29, 2022 | Buy | $5.00 | 100 | 500 | 100 | Jan 03, 2023, 07:05 AM |
Dahms Bradford D. | Chief Financial Officer | Nov 30, 2022 | Buy | $6.66 | 1,502 | 9,999 | 6,142 | Dec 01, 2022, 04:35 PM |
CLACKSON TIMOTHY P | President and CEO | Nov 11, 2022 | Buy | $6.80 | 2,500 | 16,995 | 351,030 | Nov 14, 2022, 04:12 PM |
GORDON CARL L | Director | Nov 07, 2022 | Buy | $5.21 | 192,000 | 1,000,320 | 16,734,518 | Nov 09, 2022, 04:29 PM |
ORBIMED ADVISORS LLC | Director | Nov 07, 2022 | Buy | $5.21 | 192,000 | 1,000,320 | 16,734,518 | Nov 09, 2022, 04:25 PM |
GORDON CARL L | Director | Jan 19, 2022 | Buy | $9.97 | 11,521 | 114,864 | 16,395,756 | Jan 21, 2022, 07:22 PM |
GORDON CARL L | Director | Jan 21, 2022 | Buy | $9.97 | 111,896 | 1,115,603 | 16,542,652 | Jan 21, 2022, 07:22 PM |
GORDON CARL L | Director | Jan 20, 2022 | Buy | $9.95 | 35,000 | 348,250 | 16,430,756 | Jan 21, 2022, 07:22 PM |
ORBIMED ADVISORS LLC | Director | Jan 21, 2022 | Buy | $9.97 | 111,896 | 1,115,603 | 16,542,652 | Jan 21, 2022, 07:18 PM |
ORBIMED ADVISORS LLC | Director | Jan 20, 2022 | Buy | $9.95 | 35,000 | 348,250 | 16,430,756 | Jan 21, 2022, 07:18 PM |
ORBIMED ADVISORS LLC | Director | Jan 19, 2022 | Buy | $9.97 | 11,521 | 114,864 | 16,395,756 | Jan 21, 2022, 07:18 PM |
GORDON CARL L | Director | Jan 13, 2022 | Buy | $9.43 | 17,320 | 163,328 | 16,384,235 | Jan 13, 2022, 07:27 PM |
GORDON CARL L | Director | Jan 12, 2022 | Buy | $10.06 | 18,897 | 190,104 | 16,366,915 | Jan 13, 2022, 07:27 PM |
GORDON CARL L | Director | Jan 11, 2022 | Buy | $10.51 | 8,500 | 89,319 | 16,348,018 | Jan 13, 2022, 07:27 PM |
ORBIMED ADVISORS LLC | Director | Jan 13, 2022 | Buy | $9.43 | 17,320 | 163,328 | 16,384,235 | Jan 13, 2022, 07:18 PM |
ORBIMED ADVISORS LLC | Director | Jan 12, 2022 | Buy | $10.06 | 18,897 | 190,104 | 16,366,915 | Jan 13, 2022, 07:18 PM |
ORBIMED ADVISORS LLC | Director | Jan 11, 2022 | Buy | $10.51 | 8,500 | 89,319 | 16,348,018 | Jan 13, 2022, 07:18 PM |
CLACKSON TIMOTHY P | President and CEO | Dec 21, 2021 | Buy | $9.76 | 2,600 | 25,381 | 348,530 | Dec 22, 2021, 06:26 PM |
Dahms Bradford D. | Chief Financial Officer | Dec 21, 2021 | Buy | $10.15 | 1,970 | 20,000 | 1,970 | Dec 22, 2021, 06:21 PM |
GORDON CARL L | Director | Oct 12, 2021 | Buy | $16.00 | 62,500 | 1,000,000 | 499,150 | Oct 14, 2021, 05:00 PM |
GORDON CARL L | Director | Oct 12, 2021 | Buy | $16.00 | 562,500 | 9,000,000 | 16,339,518 | Oct 14, 2021, 05:00 PM |
Shakespeare William | See Remarks | Oct 12, 2021 | Buy | $16.00 | 625 | 10,000 | 388,949 | Oct 14, 2021, 05:00 PM |
Rock Springs Capital Management LP | 10% Owner | Oct 12, 2021 | Buy | $16.00 | 250,000 | 4,000,000 | 599,320 | Oct 14, 2021, 05:00 PM |
ORBIMED ADVISORS LLC | Director | Oct 12, 2021 | Buy | $16.00 | 562,500 | 9,000,000 | 16,339,518 | Oct 14, 2021, 05:00 PM |
ORBIMED ADVISORS LLC | Director | Oct 12, 2021 | Buy | $16.00 | 62,500 | 1,000,000 | 499,150 | Oct 14, 2021, 05:00 PM |
Omega Fund VI, L.P. | Former 10% owner | Oct 12, 2021 | Buy | $16.00 | 187,500 | 3,000,000 | 711,479 | Oct 14, 2021, 04:40 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN THESEUS PHARMACEUTICALS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
ORBIMED ADVISORS LLC | 17,713,600 | 1.43% | Exited | Other |
BLACKROCK INC. | 1,425,234 | 0.00015% | Exited | Other |
GEODE CAPITAL MANAGEMENT, LLC | 407,822 | 0.00017% | Exited | Other |
RENAISSANCE TECHNOLOGIES LLC | 271,600 | 0.0017% | Exited | Other |
UBS OCONNOR LLC | 12,517 | 0.00248% | Exited | Value |
CHANGE IN SHARES OUTSTANDING FOR THESEUS PHARMACEUTICALS INC
STOCK BUYBACKS FOR THESEUS PHARMACEUTICALS INC
Load More
Period of Report: 09/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2023
0.15%
1Q
03/31/2023
3.38%
2Q
12/31/2022
13.17%
3Q
09/30/2022
13.52%
4Q
06/30/2022
14.02%
5Q
03/31/2022
14.52%
6Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR THESEUS PHARMACEUTICALS INC
LOADING...